http://www.bing.com/news/search?q=biosimilar&FORM=BNFD&format=rssSearch resultshttp://www.bing.com/rsslogo.gifhttp://www.bing.com/news/search?q=biosimilar&FORM=BNFD&format=rssCopyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a0b68eb819444a1a16bcc107260e826&url=https%3a%2f%2fwww.empr.com%2fnews%2ffda-greenlights-first-interchangeable-golimumab-biosimilars%2f&c=10916323983666737290&mkt=en-usTwo interchangeable golimumab biosimilars were approved for the treatment of rheumatoid arthritis and ulcerative colitis.Mon, 18 May 2026 08:35:00 GMTMPRhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a0b68eb819444a1a16bcc107260e826&url=https%3a%2f%2fdrugstorenews.com%2fiqvia-kexing-biopharm-partner-ai-driven-biosimilar-development&c=14541251787047077670&mkt=en-usThe collaboration integrates IQVIA’s AI‑enabled clinical trial capabilities to enhance speed and efficiency, per the companies.Mon, 18 May 2026 09:00:00 GMTDrug Store Newshttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a0b68eb819444a1a16bcc107260e826&url=https%3a%2f%2fwww.msn.com%2fen-us%2fmoney%2ftopstocks%2falvotech-plans-june-fda-resubmissions-sees-biosimilar-approvals-by-year-end%2far-AA2386ZQ&c=1188423730441620443&mkt=en-usTeva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem Alvotech (NASDAQ:ALVO) Chief Strategy Officer Balaji Prasad said the biosimilar developer is preparing to resubmit three biologics ...Wed, 13 May 2026 17:13:28 GMTMarketBeat on MSNhttp://www.bing.com/th?id=ONUT.tGoLMnYv-H6TIuYlCW7RPA&pid=Newsw={0}&h={1}&c=141200675http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a0b68eb819444a1a16bcc107260e826&url=https%3a%2f%2ffinance.yahoo.com%2fsectors%2fhealthcare%2farticles%2fiqvias-iqv-ai-driven-biosimilar-121127117.html&c=10810639151666519315&mkt=en-usEarlier this week, IQVIA Holdings announced an expanded collaboration with Kexing Biopharm to support a global, multi-product biosimilar development and commercialization program using its AI-enabled ...Fri, 15 May 2026 05:49:00 GMTYahoo Financehttp://www.bing.com/th?id=ONUT.scmaLKWLFd1dpf7uFqSMaw&pid=Newsw={0}&h={1}&c=141194432http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a0b68eb819444a1a16bcc107260e826&url=https%3a%2f%2fseekingalpha.com%2fnews%2f4593069-patent-lawsuits-slowing-biosimilar-access-market-optum-rx-ceo&c=15314358042404992818&mkt=en-usA key sticking point to greater adoption of biosimilar medications by health plans are lawsuits from brand manufacturers seeking to delay those treatments from coming to market, according to Optum ...Thu, 14 May 2026 08:11:00 GMTSeeking Alphahttp://www.bing.com/th?id=ONUT.0FouvGi5ws6SrIAacPxPkw&pid=Newsw={0}&h={1}&c=14630420http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a0b68eb819444a1a16bcc107260e826&url=https%3a%2f%2fwww.fiercehealthcare.com%2fproviders%2fcvs-expand-biosimilar-formulary-adoptions-improve-affordability-accessibility&c=12956746810741512537&mkt=en-usCVS announced Tuesday it will expand its use of lower-cost biosimilars and tr | The move to prioritize biosimilars comes as the company seeks to improve affordability, access and value. Changes will ...Tue, 05 May 2026 08:15:00 GMTFierce Healthcarehttp://www.bing.com/th?id=ONUT.Oxqe-6PbKU3yzdkA3GiPTw&pid=Newsw={0}&h={1}&c=1419201080http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a0b68eb819444a1a16bcc107260e826&url=https%3a%2f%2fkalkinemedia.com%2fus%2fstocks%2fhealthcare%2fis-iqvia-ai-biosimilar-deal-boosting-nyse-composite-health&c=1892606619530945327&mkt=en-usNYSE Composite attention surrounds IQVIA after expanded artificial intelligence clinical collaboration with Kexing Biopharm strengthened healthcare research coordination and digital trial management ...Thu, 14 May 2026 03:30:00 GMTKalkine Mediahttp://www.bing.com/th?id=ONUT.I3Y_bttqfj2UJ3p6-hvPjA&pid=Newsw={0}&h={1}&c=141000667http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a0b68eb819444a1a16bcc107260e826&url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2fviatris-unloads-biosimilar-business-partner-biocon-33b&c=4139599147680456671&mkt=en-usViatris is leaving the biosimilar field just months after winning the landmark FDA approval for the first interchangeable biosimilar product. Biocon Biologics, a subsidiary of Biocon, will buy Viatris ...Sun, 27 Feb 2022 20:57:00 GMTFiercePharmahttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a0b68eb819444a1a16bcc107260e826&url=https%3a%2f%2fwww.ajmc.com%2fview%2fbiosimilar-adoption-and-provider-performance-in-medicare-value-based-payment-models&c=6181684120878289263&mkt=en-usEvidence suggests that adoption of oncology biosimilars in Medicare value-based payment models has produced substantial cost savings and improved provider financial performance. Objectives: To ...Tue, 05 May 2026 09:24:00 GMTThe American Journal of Managed Carehttp://www.bing.com/th?id=ONUT.7ShbnOQlxlEZyFrVFUJPkA&pid=Newsw={0}&h={1}&c=1450012626http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a0b68eb819444a1a16bcc107260e826&url=https%3a%2f%2fwww.healthaffairs.org%2fcontent%2fforefront%2fbiosimilar-approvals-and-bpcia-too-soon-give-up&c=86341426276725141&mkt=en-usThe Biologics Price Competition and Innovation Act (BPCIA), part of the 2010 Affordable Care Act, sought to drive down prices for biologics, much as the 1984 Hatch-Waxman Act did for small-molecule ...Thu, 18 Jul 2019 17:00:00 GMTHealth Affairs